Molecular strain typing of M. tuberculosis isolates

from a suspected outbreak involving a faulty

bronchoscope by Shorten, R.J. et al.
Sir,
There are many reports of transmission of mycobacteria by contaminated bronchoscopes 1-8. 
We undertook a retrospective investigation after a bronchoscope was found to be faulty and 
could not be decontaminated effectively. This revealed that Mycobacterium tuberculosis had 
been isolated from four patients who had had broncho-alveolar lavage specimens collected 
using this instrument.   A specimen from a fifth patient was culture negative, but positive by 
a  nucleic  acid  amplification  technique  (Becton  Dickinson  ProbeTec  strand  displacement 
amplification SDA method). 
It was possible that the four M. tuberculosis culture positive patients had genuine infections, 
or that their specimens had been cross contaminated by the faulty bronchoscope during the 
procedure  or  that  contamination  had  occurred  within  the  laboratory.  To  clarify  this,  the 
organisms were strain-typed 9.
The  current  international  gold  standard  for  strain  typing  M.  tuberculosis  is  restriction 
fragment length polymorphism (RFLP) using the insertion sequence IS6110 10.  In order to 
perform this method, 200ng high quality DNA is required, which can only be obtained from 
cultures incubated for a considerable length of time, often more than 6 weeks. As a rapid 
alternative  approach,  MIRU-typing  (mycobacterial  interspersed  repeating  units)  has  been 
proposed. MIRU typing is a polymerase chain reaction (PCR) based tool 11, 12. MIRU typing 
provides different sized PCR products related to the number of tandem repeats that a strain 
possesses at 12 different genomic loci and is simple and rapid to perform resulting in a 12 
digit strain type that can be compared between isolates. This method also has the advantage 
of using smaller quantities of poor quality DNA, and can therefore be performed on much 
younger cultures than RFLP and may also be performed directly on clinical specimens. For 
these reasons, the four M. tuberculosis isolates, together with the specimen from the SDA-
positive patient were investigated by the MIRU methodology. Table I: MIRU patterns for the four isolates. 
PCR products could not be generated from the specimen from the SDA-positive patient as the 
SDA  extraction  method  proved  unsuitable  for  use  with  the  MIRU  PCR  and  insufficient 
sample  remained  to  extract  mycobacterial  DNA  by  a  suitable  protocol.  Products  were 
generated from the DNA extracted from liquid media culture from the other four patients.
The four isolates possess distinct MIRU patterns and therefore, there is no evidence that 
cross contamination or nosocomial cross infection has occurred (see Table I).  
Had  these  specimens  been  typed  using  IS6110  RFLP,  these  results  would  have  taken  a 
minimum  of  4  weeks  rather  than  the  one  week  turnaround  for  MIRU  at  our  laboratory. 
Currently there is not an extensive database of MIRU typing as there is for IS6110, so the 
wider applications of the latter method have obvious benefits. However, in small suspected 
outbreaks, such as the one described, the MIRU typing is invaluable in providing a definitive, 
rapid result which can guide clinical practice.
MIRU loci and corresponding alleles
Isolate 2 4 10 16 20 232 24 262 27 31 39 40
03:409 Patient A 2 2 2 2 2 5 1 7 3 5 4
3
03:420 Patient B 2 2 3 4 1 5 1 1 3 3 2
2
03:434 Patient C 2 2 3 1 2 8 1 5 2 3 2
1
03:485 Patient D 2 2 5 1 2 5 1 1 3 3 2
2
Table I: MIRU patterns for the four isolates.
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